Abstract
Objective: To evaluate the utilization trends of antidiabetics in Hungary.
Method: The analysis includes the drugs of antidiabetic therapy which were registered between 1998 and 2002 in Hungary. The consumption of antidiabetic drugs was analyzed by the ATC/Defined Daily Dose (DDD) method. The data used in this study were derived from the National Health Insurance and from MIS Consulting Company.
Results: Between 1998 and 2002, the total consumption of antidiabetics increased by 41.8%, and reached 47.59 DDD/1000 inhabitants/day in 2002. The consumption of oral antidiabetics (OAD) increased by 33.41% (33.86 DDD/1000 inhabitants/d ay in 2002), while in the case of insulin the increase was 67.8% (13.74 DDD/1000 inhabitants/day). Sulphonylureas were the most frequently used class (21.11 DDD/1000 inhabitants/day in 2002). Glibenclamide was the most frequently used antidiabetic drug (12.63 DDD/1000 inhabitants/day in 2002).
Conclusion: The insulin class had greater emphasis in therapy. Among OAD, the consumption rate of sulphonylureas decreased and the consumption rate of Biguanides and acarbose increased. By 2002 metformin replaced 90% of the buformin in use. The limited effect of therapeutic recommendations could explain these changes, although the out-of-date buformin and the non-micronized glibenclamide were still in use in 2002.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
W Sarah R Gojka G Anders S Richard K. Hilary (2004) ArticleTitleGlobal prevalence of diabetes Diabet Care 27 1047–53
K Hilary EA Ronald HH. William (1998) ArticleTitleGlobal burden of diabetes, 1995–2025 Diabet Care 21 1414–31
KGMM Alberti PZ. Zimmet (1998) ArticleTitleDefinition, diagnosis and classification of diabetes mellitus and its complications. Part I: Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation Diabet Med 15 539–53 Occurrence Handle10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S Occurrence Handle9686693
InstitutionalAuthorNameUK Prospective Diabetes Study Group. (1998) ArticleTitleIntensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 837–53
InstitutionalAuthorNameDCCT Research Group. (1993) ArticleTitleThe effect of intensive treatment of diabetes ont he developement and progression of long-term complications in insulin-dependent diebetes mellitus N Engl J Med 329 977–86
InstitutionalAuthorNameInternational Diabetes Federation. (1999) ArticleTitleA desktop guide to type 2 diabetes Diabetic Med 16 716–30
InstitutionalAuthorNameHungarian Diabetes Association. (1999) ArticleTitleThe classification, the treatment and the care of diabetes mellitus national guideline Diabetol Hungarica 7 44–57
F Viliam P Michaela T. Tomas (2003) ArticleTitlePharmacotherapy of diabetes mellitus and its economic consequences int he Slovak Republic J Soc Admin Pharm 20 77–9
JB Stephen W Jenifer F James CYS Jennifer BS Amishi K. Jennifer (2001) ArticleTitleUtilization of oral hypoglycemic agents in a drug-insured U.S. population Diabet Care 24 1411–15
EW Per G. Catharina (2002) ArticleTitleDrug prescription in men and women with type-2 diabetes in Stockholm in 1995 and 2001: change over time Eur J Clin Pharmacol 58 547–53 Occurrence Handle10.1007/s00228-002-0510-1 Occurrence Handle12451433
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hankó, B., Tukarcs, É., Kumli, P. et al. Antidiabetic Drug Utilization in Hungary. Pharm World Sci 27, 263–265 (2005). https://doi.org/10.1007/s11096-004-5804-1
Issue Date:
DOI: https://doi.org/10.1007/s11096-004-5804-1